Benin Management Corp’s Bionano Genomics BNGO Stock Holding History

Benin Management Corp’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20	Closed	-$7.32K	–	101
2023 Q2	$7.32K	Hold	20	–	–	﹤0.01%	97
2023 Q1	$13.3K	Hold	20	–	–	0.01%	100
2022 Q4	$17.5K	Hold	20	–	–	0.01%	96
2022 Q3	$22K	Hold	20	–	–	0.01%	92
2022 Q2	$17K	Hold	20	–	–	0.01%	97
2022 Q1	$31K	Hold	20	–	–	0.01%	104
2021 Q4	$36K	Hold	20	–	–	0.01%	102
2021 Q3	$66K	Hold	20	–	–	0.02%	102
2021 Q2	$88K	Hold	20	–	–	0.03%	104
2021 Q1	$97K	Hold	20	–	–	0.03%	99
2020 Q4	$37K	Hold	20	–	–	0.01%	94
2020 Q3	$8K	Buy	+20	New	+$7.75K	﹤0.01%	88

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Benin Management Corp's BNGO Position: Q3 2023 in Review

Benin Management Corp sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 20 shares — an estimated $7.32K sold.

Benin Management Corp first reported a position in BNGO in Q3 2020 and held it in 12 quarters. The position peaked at $97K in Q1 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Benin Management Corp reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
Benin Management Corp sold 20 Bionano Genomics shares in Q3 2023, an estimated $7.32K.
Benin Management Corp first reported a position in Bionano Genomics in Q3 2020 and held it in 12 quarters.
Benin Management Corp's Bionano Genomics position peaked at $97K in Q1 2021.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Benin Management Corp's 13F filing for Q3 2023, filed 19 Oct 2023.